CD123 drugs for Acute Myeloid Leukemia
5 tracked CD123 drugs in the Acute Myeloid Leukemia race. The class explanation lives on the CD123 page; the full indication pipeline across every mechanism is on the Acute Myeloid Leukemia page.
1 Phase 2/31 Phase 21 Phase 1/22 Phase 1
Head-to-head evidence: Allo-RevCAR01-T vs CD123 targeted CAR-NK cells · Allo-RevCAR01-T vs Tagraxofusp · BYON4413 vs CD123 targeted CAR-NK cells · BYON4413 vs Tagraxofusp · CD123 targeted CAR-NK cells vs Pivekimab Sunirine · CD123 targeted CAR-NK cells vs Tagraxofusp